Neuroscience-based nomenclature (NbN) is a classification system for psychotropic medications based on pharmacology and mode of action. Rather than the current naming system, which is primarily based on a single indication or its chemical structure, NbN uses current scientific knowledge that provides a pharmacological rationale for medication choice. NbN limits confusion, especially when prescribing to children, as the medications are named and described in a way that is not stigmatizing or misleading. [Journal of Psychosocial Nursing and Mental Health Services, 61(7), 9-13.].